phosphatidylcholines has been researched along with probucol in 9 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (probucol) | Trials (probucol) | Recent Studies (post-2010) (probucol) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 1,488 | 174 | 317 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | probucol (IC50) |
|---|---|---|---|
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 1.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotoh, N; Komuro, E; Niki, E; Noguchi, N; Shimizu, K; Tsuchiya, J | 1 |
| McLean, LR; Ohlweiler, DF; Parker, RA; Thomas, CE | 1 |
| Hagaman, KA; McLean, LR | 1 |
| Pezeshk, A; Pezeshk, V; Subczynski, WK; Wojas, J | 1 |
| Tsujita, M; Yokoyama, S | 1 |
| Baba, N; Kaneko, T; Matsuo, M | 1 |
| Hashida, M; Hattori, Y; Kawakami, S; Yamashita, F | 1 |
| Adorni, MP; Bernini, F; Calabresi, L; Favari, E; Franceschini, G; Jessup, W; Simonelli, S | 1 |
| Fujino, H; Kawashima, T; Makiyama, T; Matsuzawa, Y; Murayama, T; Yamaura, E; Yamazaki, R | 1 |
9 other study(ies) available for phosphatidylcholines and probucol
| Article | Year |
|---|---|
Antioxidant activities of probucol against lipid peroxidations.
Topics: Antioxidants; Benzhydryl Compounds; Copper; Electron Spin Resonance Spectroscopy; Free Radicals; Hexanes; Humans; Linoleic Acids; Lipid Peroxidation; Lipoproteins, LDL; Liposomes; Oxidation-Reduction; Phosphatidylcholines; Probucol; Vitamin E | 1992 |
Ascorbate and phenolic antioxidant interactions in prevention of liposomal oxidation.
Topics: Antioxidants; Ascorbic Acid; Drug Synergism; Lipid Peroxidation; Liposomes; Oxidation-Reduction; Phenols; Phosphatidylcholines; Probucol; Sulfides; Vitamin E | 1992 |
Antioxidant activity of probucol and its effects on phase transitions in phosphatidylcholine liposomes.
Topics: Antioxidants; Calorimetry, Differential Scanning; Dimyristoylphosphatidylcholine; Lipid Bilayers; Lipid Peroxidation; Liposomes; Phosphatidylcholines; Probucol; Solubility; Spectrometry, Fluorescence; Thermodynamics | 1990 |
Effects of probucol on phase transition and fluidity of phosphatidylcholine membranes: a spin label study.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Cyclic N-Oxides; Dimyristoylphosphatidylcholine; Electron Spin Resonance Spectroscopy; Lipid Bilayers; Liposomes; Membrane Fluidity; Phosphatidylcholines; Probucol; Spin Labels; Temperature; Thermodynamics | 1994 |
Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins; Cholesterol; Cholesterol Esters; Humans; Lipid Metabolism; Lipoproteins, HDL; Lipoproteins, LDL; Macrophages, Peritoneal; Methionine; Mice; Oleic Acid; Phosphatidylcholine-Sterol O-Acyltransferase; Phosphatidylcholines; Probucol; Sphingomyelins | 1996 |
Protective effect of phenolic antioxidants on the cytotoxicity induced by phosphatidylcholine hydroperoxide.
Topics: Antioxidants; Butylated Hydroxytoluene; Cell Survival; Cells, Cultured; Chromans; Endothelium, Vascular; Ethanol; Humans; Phosphatidylcholines; Probucol; Vitamin E | 2000 |
Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting.
Topics: Animals; Drug Delivery Systems; Galactose; Hepatocytes; Liposomes; Male; Mice; Phosphatidylcholines; Probucol; Tissue Distribution | 2000 |
Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1.
Topics: Alitretinoin; Animals; Apolipoprotein A-I; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cells, Cultured; CHO Cells; Cholesterol; Cricetinae; Cricetulus; Cyclic AMP; Cyclopentanes; Fibroblasts; High-Density Lipoproteins, Pre-beta; Humans; Kinetics; Macrophages; Mice; Particle Size; Phosphatidylcholines; Probucol; Rats; Scavenger Receptors, Class B; Tangier Disease; Thiosemicarbazones; Transfection; Tretinoin | 2009 |
Inhibitory effects of clinical reagents having anti-oxidative activity on transforming growth factor-β1-induced expression of α-smooth muscle actin in human fetal lung fibroblasts.
Topics: Acetylcysteine; Actins; alpha-Tocopherol; Antioxidants; Cell Line; Fetus; Fibroblasts; Humans; Hypolipidemic Agents; Lovastatin; Lung; Phosphatidylcholines; Probucol; Reactive Oxygen Species; Superoxide Dismutase; Transforming Growth Factor beta1 | 2011 |